Thermal Mandarina Sol
Glaxon's Thermal Mandarina Sol is a weight management combination product, featuring 7 transparently labeled ingredients. Each six-gram serving includes 50 mg of Niacin and 277 mg of Choline, both at clinically studied dosages. Other active compounds include 1100 mg of L-Carnitine Fumarate, 675 mg of VitaCholine, 500 mg of MitoBurn, 250 mg of InnoSlim, and 30 mg of gbbgo. The product achieved an N+ Score of 75 and a C+ grade, signifying a good quality formulation. This supplement may appeal to individuals seeking support for metabolic processes and weight management efforts.
About This Product
Thermal Mandarina Sol by Glaxon is a weight management supplement containing 7 active ingredients. It has earned an N+ Score of 75/100 (Grade C+).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Niacin, Choline.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (7 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Niacin | 50.000 mg | High |
| Choline | 277.000 mg | Adequate |
| L-Carnitine Fumarate | 1100.000 mg | N/A |
| VitaCholine | 675.000 mg | N/A |
| MitoBurn | 500.000 mg | N/A |
| gbbgo | 30.000 mg | N/A |
| InnoSlim | 250.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
